BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11008709)

  • 21. Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae.
    Abe F; Usui K; Hiraki T
    Biochemistry; 2009 Sep; 48(36):8494-504. PubMed ID: 19670905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro pharmacological study of fluconazole. Evaluation of an antifungal assay].
    Duval F; Lavarde V
    Pathol Biol (Paris); 1993 May; 41(5):469-73. PubMed ID: 8414680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic architecture of Hsp90-dependent drug resistance.
    Cowen LE; Carpenter AE; Matangkasombut O; Fink GR; Lindquist S
    Eukaryot Cell; 2006 Dec; 5(12):2184-8. PubMed ID: 17056742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The G464S amino acid substitution in Candida albicans sterol 14alpha-demethylase causes fluconazole resistance in the clinic through reduced affinity.
    Kelly SL; Lamb DC; Loeffler J; Einsele H; Kelly DE
    Biochem Biophys Res Commun; 1999 Aug; 262(1):174-9. PubMed ID: 10448088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiological effects of an antimycotic azasterol on cultures of Saccharomyces cerevisiae.
    Hays PR; Neal WD; Parks LW
    Antimicrob Agents Chemother; 1977 Aug; 12(2):185-91. PubMed ID: 332071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
    Yamaguchi H
    Rinsho Byori; 1997 Jul; Suppl 105():182-90. PubMed ID: 9379538
    [No Abstract]   [Full Text] [Related]  

  • 27. New challenges to the therapy of systemic fungal infections.
    Medoff G
    Trans Am Clin Climatol Assoc; 1996; 107():146-57; discussion 157-8. PubMed ID: 8725568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
    Buchta V; Vejsova M; Vale-Silva LA
    Folia Microbiol (Praha); 2008; 53(2):153-60. PubMed ID: 18837162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MPR1 as a novel selection marker in Saccharomyces cerevisiae.
    Ogawa-Mitsuhashi K; Sagane K; Kuromitsu J; Takagi H; Tsukahara K
    Yeast; 2009 Nov; 26(11):587-93. PubMed ID: 19750564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.
    Cabral ME; Figueroa LI; Fariña JI
    Rev Iberoam Micol; 2013 Jan; 30(1):31-8. PubMed ID: 23069981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and susceptibility of Saccharomyces cerevisiae causing vaginitis in Greek women.
    Papaemmanouil V; Georgogiannis N; Plega M; Lalaki J; Lydakis D; Dimitriou M; Papadimitriou A
    Anaerobe; 2011 Dec; 17(6):298-9. PubMed ID: 21549212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid identification of fluconazole resistance using Chromagar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
    Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extra-chromosomal inheritance of rhodamine 6G resistance in Saccharomyces cerevisiae.
    Carignani G; Lancashire WE; Griffiths DE
    Mol Gen Genet; 1977 Feb; 151(1):49-56. PubMed ID: 325367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs.
    Kim J; Campbell B; Mahoney N; Chan K; Molyneux R; May G
    Biochem Biophys Res Commun; 2008 Jul; 372(1):266-71. PubMed ID: 18486603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic control analysis and engineering of the yeast sterol biosynthetic pathway.
    Groeneveld P; Rolley N; Kell DB; Kelly SL; Kelly DE
    Mol Biol Rep; 2002; 29(1-2):27-9. PubMed ID: 12241069
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural and functional study of YER067W, a new protein involved in yeast metabolism control and drug resistance.
    Domitrovic T; Kozlov G; Freire JC; Masuda CA; da Silva Almeida M; Montero-Lomeli M; Atella GC; Matta-Camacho E; Gehring K; Kurtenbach E
    PLoS One; 2010 Jun; 5(6):e11163. PubMed ID: 20567505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of a mitochondrial mutant of Saccharomyces cerevisiae resistant to Rhodamine 6G [proceedings].
    Nichols WW; Briggs C; Woodrow JR; Haslam JM
    Biochem Soc Trans; 1977; 5(5):1494-6. PubMed ID: 336435
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction by manganese of mitochondrial antibiotic resistance mutations in yeast.
    Putrament A; Baranowska H; Prazmo W
    Mol Gen Genet; 1973 Nov; 126(4):357-66. PubMed ID: 4593998
    [No Abstract]   [Full Text] [Related]  

  • 40. Outer penetration barrier of Escherichia coli K-12: kinetics of the uptake of gentian violet by wild type and envelope mutants.
    Gustafsson P; Nordström K; Normark S
    J Bacteriol; 1973 Nov; 116(2):893-900. PubMed ID: 4583255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.